Skip to content
MedsAcross

Brand family

Alunbrig

Brigatinib · Takeda Pharmaceuticals
United States
Presentations
4
Markets
1

Alunbrig is a brand of Brigatinib marketed by Takeda Pharmaceuticals, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Brigatinib
Brand owner
Takeda Pharmaceuticals
Registered in
United States
Strengths and forms
kit, 180 mg tablet, 30 mg tablet, 90 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Alunbrig kitTakeda PharmaceuticalsUS FDAAvailable on request
Alunbrig 180 mg tabletOralTakeda PharmaceuticalsUS FDAAvailable on request
Alunbrig 30 mg tabletOralTakeda PharmaceuticalsUS FDAAvailable on request
Alunbrig 90 mg tabletOralTakeda PharmaceuticalsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Alunbrig

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.